Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth

Biochemical and Biophysical Research Communications

Volumn 312, Issue 3, 2003, Pages 801-805

  He, Guo An ^a   Luo, Jin Xian ^a   Zhang, Tian Yuan ^a   Wang, Fang Yu ^a   Li, Rui Fang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Antitumor activity; Apoptosis; Canstatin; Canstatin N; Endothelial cell proliferation; Inhibition; Type IV collagen

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CANSTATIN; CANSTATIN N; COLLAGEN TYPE 4; CONSTATIN (1 89); CONSTATIN (1-89); PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CELL DIVISION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; ESCHERICHIA COLI; FIBROBLAST; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG; MALE; MELANOMA; MOUSE; MOUSE STRAIN; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE; TUMOR GROWTH; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ESCHERICHIA COLI; MURINAE;

EID: 0344983831     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.003     Document Type: Article

References (20)

1. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg. 175:1972;409-416.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31.
3. Timpl R. Macromolecular organization of basement membranes. Curr. Opin. Cell Biol. 8:1996;618-624.
4. Prockop D.J., Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 64:1995;403-434.
5. Timpl R., Wiedemann H., van Delden V., Furthmayr H., Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur. J. Biochem. 120:1981;203-211.
6. Colorado P.C., Torre A., Kamphaus G.D., Maeshima Y., Hopfer H., Takahashi K., Volk R., Zamborsky E.D., Herman S., Sarkar P.K., Ericksen M.B., Dhanabal M., Simons M., Post M., Kufe D.W., Weichselbaum R.R., Sukhatme V.P., Kalluri R. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60:2000;2520-2526.
7. Kamphaus G.D., Colorado P.C., Panka D.J., Hopfer H., Ramchandran R., Torre A., Maeshima Y., Mier J.W., Sukhatme V.P., Kalluri R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J. Biol. Chem. 275:2000;1209-1215.
8. Panka D.J., Mier J.W. Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells. J. Biol. Chem. 278:2003;37632-37636.
9. Maeshima Y., Colorado P.C., Kalluri R. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J. Biol. Chem. 275:2000;23745-23750.
10. Maeshima Y., Sudhakar A., Lively J.C., Ueki K., Kharbanda S., Kahn C.R., Sonenberg N., Hynes R.O., Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science. 295:2002;140-143.
11. Maeshima Y., Colorado P.C., Torre A., Holthaus K.A., Grunkemeyer J.A., Ericksen M.B., Hopfer H., Xiao Y., Stillman I.E., Kalluri R. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J. Biol. Chem. 275:2000;21340-21348.
12. Maeshima Y., Manfredi M., Reimer C., Holthaus K.A., Hopfer H., Chandamuri B.R., Kharbanda S., Kalluri R. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J. Biol. Chem. 276:2001;15240-15248.
13. Maeshima Y., Yerramalla U.L., Dhanabal M., Holthaus K.A., Barbashov S., Kharbanda S., Reimer C., Manfredi M., Dickerson W.M., Kalluri R. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J. Biol. Chem. 276:2001;31959-31968.
14. Han J., Ohno N., Pasco S., Monboisse J.C., Borel J.P., Kefalides N.A. A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells. J. Biol. Chem. 272:1997;20395-20401.
15. He G.A., Luo J.X., Zhang T.Y., Hu Z.S., Li R.F. Cloning and expression of human canstatin and its purification and bioactivity. Acta Microbiol. Sin. 43:2003;608-612.
16. He G.A., Luo J.X., Zhang T.Y., Hu Z.S., Gu Q.L. Expression and purification of the N-domain of human canstatin and its bioactivity. Acta Biochim. Biophys. Sin. 35:2003;483-487.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
18. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
19. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:1994;315-328.
20. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285.